457 related articles for article (PubMed ID: 17397762)
21. Iron in sickle-cell disease: what have we learned over the years?
Inati A; Khoriaty E; Musallam KM
Pediatr Blood Cancer; 2011 Feb; 56(2):182-90. PubMed ID: 21157888
[TBL] [Abstract][Full Text] [Related]
22. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
[TBL] [Abstract][Full Text] [Related]
23. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
Win N; Sinha S; Lee E; Mills W
Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
[TBL] [Abstract][Full Text] [Related]
24. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy.
Wali YA; al Okbi H; al Abri R
Pediatr Hematol Oncol; 2003; 20(1):7-13. PubMed ID: 12687748
[TBL] [Abstract][Full Text] [Related]
25. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
26. Sickle cell disease; a general overview.
Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
[TBL] [Abstract][Full Text] [Related]
27. Pain syndromes in sickle cell disease: an update.
Niscola P; Sorrentino F; Scaramucci L; de Fabritiis P; Cianciulli P
Pain Med; 2009 Apr; 10(3):470-80. PubMed ID: 19416438
[TBL] [Abstract][Full Text] [Related]
28. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
[TBL] [Abstract][Full Text] [Related]
29. Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease.
Goldberg JS
Med Hypotheses; 2010 Apr; 74(4):629-30. PubMed ID: 20022432
[TBL] [Abstract][Full Text] [Related]
30. The pathophysiology, prevention, and treatment of stroke in sickle cell disease.
Wang WC
Curr Opin Hematol; 2007 May; 14(3):191-7. PubMed ID: 17414206
[TBL] [Abstract][Full Text] [Related]
31. Infection in sickle cell disease: a review.
Booth C; Inusa B; Obaro SK
Int J Infect Dis; 2010 Jan; 14(1):e2-e12. PubMed ID: 19497774
[TBL] [Abstract][Full Text] [Related]
32. Management of sickle cell disease: a review.
Aluoch JR
East Afr Med J; 1991 Jul; 68(7):576-81. PubMed ID: 1661667
[TBL] [Abstract][Full Text] [Related]
33. When to transfuse blood in sickle cell disease? Lessons from Jehovah's Witnesses.
Pearlman ES; Ballas SK
Ann Clin Lab Sci; 1994; 24(5):396-400. PubMed ID: 7818235
[TBL] [Abstract][Full Text] [Related]
34. Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, Physiological issues.
Simon K; Lobo ML; Jackson S
J Pediatr Nurs; 1999 Oct; 14(5):281-95. PubMed ID: 10554441
[TBL] [Abstract][Full Text] [Related]
35. An evidence-based approach to the treatment of adults with sickle cell disease.
Lottenberg R; Hassell KL
Hematology Am Soc Hematol Educ Program; 2005; ():58-65. PubMed ID: 16304360
[TBL] [Abstract][Full Text] [Related]
36. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
[TBL] [Abstract][Full Text] [Related]
37. [Physiopathological basis of sickle cell disease, management and current therapeutics].
Galacteros F
Bull Soc Pathol Exot; 2001 May; 94(2):77-9. PubMed ID: 11475031
[TBL] [Abstract][Full Text] [Related]
38. Plasma exchange in critically ill patients with sickle cell disease.
Boga C; Kozanoglu I; Ozdogu H; Ozyurek E
Transfus Apher Sci; 2007 Aug; 37(1):17-22. PubMed ID: 17707694
[TBL] [Abstract][Full Text] [Related]
39. Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines.
Field JJ; Knight-Perry JE; Debaun MR
Curr Opin Hematol; 2009 May; 16(3):173-8. PubMed ID: 19295432
[TBL] [Abstract][Full Text] [Related]
40. Opportunities to improve outcomes in sickle cell disease.
Mehta SR; Afenyi-Annan A; Byrns PJ; Lottenberg R
Am Fam Physician; 2006 Jul; 74(2):303-10. PubMed ID: 16883928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
